Perth-based neurology research company NeuroDiscovery Ltd's subsidiary NeuroSolutions Ltd will provide services to the UK division of a major biopharmaceutical firm for two years with intial work plans worth $200,000, the company announced today.
The full text of a company announcement is pasted below:
NeuroDiscovery Ltd, a neurology focused biotechnology research and development company, is pleased to announce its 100%subsidiary, NeuroSolutions Ltd has entered into a two year Master Services Agreement with the United Kingdom division of a major US and European based biopharmaceutical company.
The Agreement provides for the provision of NeuroSolutions specialist electrophysiology services over a two year period with agreed initial work plans commencing immediately with an approximate value of $200,000.
Additional work plans are also now under discussion.
NeuroDiscovery's Chairman, Dr Mark Treherne said, "We are delighted that NeuroSolutions have been appointed as an electrophysiology services provider of choice for this major biopharmaceutical company and we look forward to a long and successful working relationship with our valued partner over the next two years."
For commercially sensitive reasons NeuroDiscovery is not able to name the major biopharmaceutical company.
